28 nov.: Quam Announces 2012/13 Interim Results
28 nov.: UPDATE: South Korea October Current-Account Surplus Narrows; Beat..
28/11/2012 03:28:00

Korea Finance Corp: To Extend Due-Diligence Period for Korea Aerospace Sale to Dec 7

By Kanga Kong

SEOUL--Major shareholders of Korea Aerospace Industries Ltd. (0478410.SE) have extended by two weeks the due diligence process for the bidding of their combined 41.8% stake in the airplane components maker, worth an estimated $1 billion.

"We decided to extend the due-diligence period to Dec. 7 and take final bids by Dec. 17 due to the requests by preliminary bidders," Korea Finance Corp., KAI's largest shareholder, said Wednesday in a statement.

Two preliminary bidders, Korean Air Lines Co. (003490.SE) and Hyundai Heavy Industries, have asked the sellers for an extension, saying they couldn't complete due diligence by Nov. 23, as originally scheduled, as they faced strong resistance from KAI's labor union to complete the process.

Most analysts say the deal is unlikely to close by the year-end--as targeted by the key shareholders--or may fall through as some lawmakers are against the deal, particularly ahead of the presidential election on Dec. 19.

The deal is valued around 1.12 trillion won based on KAI's Tuesday closing price of KRW27,450.

The planned sale is the second after shareholders failed in August to attract sufficient bidding interest, with Korean Air being the sole bidder then. Under Korean law, any auction of state-owned company's assets must attract at least two bidders before it can proceed.

Korea Finance is selling 26.4% of KAI with the remaining 15.4%stake being sold by Hyundai Motor Co. (HYMLY), Doosan Group and Samsung Techwin Co. (012450.SE).

Korea Aerospace was formed in 1999 through the merger of the aerospace divisions of Samsung, Hyundai and the now-defunct Daewoo Group, during the 1997-98 Asian financial crisis.

Write to Kanga Kong at kanga.kong@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

November 27, 2012 21:28 ET (02:28 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

28 nov.: Quam Announces 2012/13 Interim Results
28 nov.: UPDATE: South Korea October Current-Account Surplus Narrows; Beat..

Envoyer un commentaire

Related debate

  • 1 semaine
  • 1 mois
  • 1 an
18 déc.
VELO
Gennemgang og analyse af Veloxis' søgsmålJeg har brugt min aften på at "hygge" mig med Veloxis netop..
60
14 déc.
GEN
Genmab kom sent fredag med en fondbørsmeddelse om en milestone på $3 milloner vedrørende deres DuoBo..
30
18 déc.
VWS
Normal 0 21 false false false DA X-NONE X-NONE ..
28
18 déc.
PNDORA
Nu har jeg købt og solgt aktier i 8 år og var os her på debatten for 4-5 år siden men har glemt mit ..
23
12 déc.
OW
  Mange danske har nok set DR’s dokumentar udsendelser om, hvad der skete med mange af de tidligere ..
18
14 déc.
VWS
Lomborg ved udmærket godt han er på gyngende grund, i mange af hans påstande.   Den værste er, når h..
17
13 déc.
VWS
Nu kører vi/Vestas den sidste måned af Q4-2014, og aktiviteten er øget måned efter måned igennem 201..
16
18 déc.
GEN
Med FDA´s godkendelse af Amgens (Micromet) godkendelse af Blincyto (blinatumomab), fik vi for alvor ..
14
14 déc.
MAERSK-B
Husk nu at en produktions nedgang på små 500000 tønder om dagen kan få prisen til at stige markant m..
12
15 déc.
GEN
Genmab har afholdt bestyrelsesmøde og valgt at give bestyrelse, direktion og ledende medarbejdere op..
11

Actualité la plus lue

  • 24 heures
  • 48 heures
  • 1 semaine
1
AB Science : nouveaux résultats cliniques positifs pour le masitinib dans le cancer colorectal métastatique
2
Atos accompagne Linedata dans sa trajectoire de virtualisation et la mise en oeuvre de son Cloud privé
3
EULER HERMES GROUP : Avenant au contrat de liquidité AMAFI signé le 9 mai 2007 entre la société Rothschild & Cie Banque et la société Euler Hermes Group
4
VALNEVA annonce l'initiation de l'essai clinique de Phase II pour son candidat vaccin contre le Clostridium difficile
5
PCAS pilotera le projet Homeskin dans le cadre du programme horizon 2020 de l'Union Européenne

Droit d'auteur Euroinvestor A/S 2014   Mentions légales et conditions d'utilisation
Information sur les cours fournies par Interactive Data.
Les données sont différées de 15 à 20 minutes selon les accords avec les différentes bourses internationales.
 
vendredi 19 décembre 2014 05:36:23
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20141211.1 - EUROWEB5 - 2014-12-19 05:36:23 - 2014-12-19 05:36:23 - 4 - Website: OKAY